Study questions maintenance approach in remitted first-episode psychosis
Research examining drug metabolism shows importance of phenotyping
Evaluating the magnitude of the interaction between valproic acid and amitriptyline
Minimal fetal risk supports use of SGAs as first-line treatment
EPA outperforms DHA in omega-3 fatty acid study for mild depression
Meta-analysis finds lithium reduces risk of suicide
Histamine system appears to have role in schizophrenia treatment
Augmentation therapy with mirtazapine shows promise in schizophrenia
In minor depression, fluoxetine does not worsen suicidal thoughts
Professionals should consider patient preferences for therapy
QTc interval prolongation and risperidone explored
From the FDA